We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-13.31%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$344M
AUM Growth
-$64.7M
Cap. Flow
-$7.41M
Cap. Flow %
-2.16%
Top 10 Hldgs %
23.5%
Holding
482
New
11
Increased
70
Reduced
80
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Healthcare 13%
3 Financials 10.57%
4 Communication Services 8.99%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POST icon
276
Post Holdings
POST
$4.09B
$1K ﹤0.01%
7
RGA icon
277
Reinsurance Group of America
RGA
$15.5B
$1K ﹤0.01%
10
SONO icon
278
Sonos
SONO
$1.87B
$1K ﹤0.01%
50
-40
-44% -$897
VONG icon
279
Vanguard Russell 1000 Growth ETF
VONG
$43.7B
$1K ﹤0.01%
16
VONV icon
280
Vanguard Russell 1000 Value ETF
VONV
$20.9B
$1K ﹤0.01%
16
VXRT
281
DELISTED
Vaxart
VXRT
$1K ﹤0.01%
200
WAB icon
282
Wabtec
WAB
$50.1B
$1K ﹤0.01%
10
DJT icon
283
Trump Media & Technology Group
DJT
$2.77B
$1K ﹤0.01%
28
AKTS
284
DELISTED
Akoustis Technologies Inc
AKTS
$1K ﹤0.01%
150
FSR
285
DELISTED
Fisker Inc.
FSR
$1K ﹤0.01%
100
PRVB
286
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
275
ACB
287
Aurora Cannabis
ACB
$175M
$0 ﹤0.01%
2
AIG icon
288
American International
AIG
$41.8B
$0 ﹤0.01%
9
ALGT icon
289
Allegiant Air
ALGT
$2.78B
-8
Closed -$1K
ALKS icon
290
Alkermes
ALKS
$8.31B
-53
Closed -$1K
ALRM icon
291
Alarm.com
ALRM
$2.75B
-35
Closed -$2K
AMED
292
DELISTED
Amedisys
AMED
-10
Closed -$2K
ARES icon
293
Ares Management
ARES
$31.3B
-17
Closed -$1K
ARWR icon
294
Arrowhead Research
ARWR
$12.1B
-45
Closed -$2K
EFOR
295
Everforth Inc
EFOR
$1.22B
-34
Closed -$4K
ATRC icon
296
AtriCure
ATRC
$1.97B
-26
Closed -$2K
AVTR icon
297
Avantor
AVTR
$9.25B
-66
Closed -$2K
AVY icon
298
Avery Dennison
AVY
$13.2B
-19
Closed -$3K
AXDX
299
DELISTED
Accelerate Diagnostics
AXDX
$0 ﹤0.01%
5
AXON
300
Axon Enterprise
AXON
$46.4B
-14
Closed -$2K

Similar funds

Providence Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Providence Capital Advisors held 482 positions worth $344M, down 16% from $408M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Providence Capital Advisors's Q2 2022 filing shows 11 new, 70 increased, 80 reduced and 174 closed positions. Its largest new stake was Aptiv: 45,637 shares worth $4.07M. The largest sale was Merck, an estimated $4.62M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Providence Capital Advisors's largest Q2 2022 buy was Aptiv: 45,637 shares worth $4.07M.
  • Providence Capital Advisors added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $5.42M increase.
  • Providence Capital Advisors's biggest Q2 2022 reduction was Merck, cutting an estimated $4.62M.
  • Providence Capital Advisors fully exited Innovator US Equity Power Buffer ETF January in Q2 2022, selling an estimated $3.75M.
  • Providence Capital Advisors's ten largest holdings make up 23% of its $344M portfolio in Q2 2022.
  • Providence Capital Advisors opened 11 new positions and closed 174 in Q2 2022.
  • Providence Capital Advisors's portfolio value fell 16% quarter-over-quarter to $344M.

Based on Providence Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.